JenaValve Technology (@JenaValve) header
JenaValve Technology (@JenaValve) profile picture

Aortic regurgitation is different. So is our valve. CAUTION: Federal (USA) law restricts these devices to sale by or on the order of a physician.

Irvine, CA
Joined January 2019
Photo by JenaValve Technology (@JenaValve)Photo by JenaValve Technology (@JenaValve)Photo by JenaValve Technology (@JenaValve)Photo by JenaValve Technology (@JenaValve)Photo by JenaValve Technology (@JenaValve)Photo by JenaValve Technology (@JenaValve)Photo by JenaValve Technology (@JenaValve)Photo by JenaValve Technology (@JenaValve)Photo by JenaValve Technology (@JenaValve)Photo by JenaValve Technology (@JenaValve)
🚨BREAKING NEWS🚨 A historic milestone for AR patients. 🇺🇸 The U.S. Food and Drug Administration has approved the Trilogy® System, the first and only dedicated TAVR therapy for high surgical risk patients with native symptomatic, severe aortic regurgitation in the U.S. For years, symptomatic, severe high-risk AR patients had limited treatment options suited to the challenges or non-calcified anatomy. The Trilogy® System changes that. Introducing a transcatheter therapy designed specifically for native AR anatomy. 👇Learn more about this major clinical advancement: jenavalve.com/trilogy-system… #FDAApproved #TAVR #Cardiology #StructuralHeart #MedTech CAUTION: Federal (USA) law restricts these devices to sale by or on the order of a physician. IMPORTANT SAFETY INFORMATION: See the link for full indications, contraindications, and cautions: jenavalve.com/#isi
1
31
3
101
16,547
Explore hands-on AR simulations in the #PCRLV Training Village, including Trilogy® System implantation across varying anatomies and TEE assessment of severe AR. Register: training-scheduler-jenavalve… @PCRonline #StructuralHeart #TAVI Medical device for professional use only. For a listing of indications, contraindications, precautions, warnings, and potential adverse events, please refer to the Instructions for Use: eifu.jenavalve.com
1
83
Join our #PCRLV symposium, "Treating severe AR in 2026: a case-based approach." Faculty will discuss the pathophysiology and clinical impact of aortic regurgitation and considerations for patient identification. 🗓 Sunday, 22 November | 🕐 5:20 PM - 6:20 PM GMT 📍 ExCeL London | Chengdu Room @PCRonline #StructuralHeart #TAVI
1
63
London calling! JenaValve will be at #PCRLV, 22–24 November, at ExCeL London, joining the structural heart community in advancing care for patients with aortic regurgitation. Details on our Symposium, Workshop, and Course to follow. @PCRonline #StructuralHeart #TAVI
1
2
205
The Trilogy® Valve's locator technology is designed to anchor without relying on calcium. The locators engage the native leaflets to support commissural alignment, secure anchoring, and precise deployment. Learn more at jenavalve.com CAUTION: Federal (United States) law restricts these devices to sale by or on the order of a physician. IMPORTANT SAFETY INFORMATION: See the link for full indications, contraindications, and cautions: jenavalve.com/#isi
68
Late-breaking at #TCT2026: TAVR for LVAD patients with aortic regurgitation. We’re exploring whether the JenaValve Trilogy™ System can help a high-risk population that doesn’t have a dedicated transcatheter solution. Join Torsten P. Vahl, MD, as he presents Transcatheter Aortic Valve Replacement with the JenaValve Trilogy System for Aortic Regurgitation in Patients with a Left Ventricular Assist Device: The JENA-VAD Study #AorticRegurgitation #TAVR #LVAD #StructuralHeart #Trilogy CAUTION: The JENAVAD study is investigational use. Limited by Federal (or United States) law to investigational use.
100
See innovation in real time. Join us for a Live Trilogy Case Presentation: TAVR AR — broadcast from @CedarsSinai Medical Center in Los Angeles, CA. 🗓 Sunday, November 1 🕐 3:50 PM — 4:50 PM PST 📍 San Diego Convention Center | Ground Level | Hall H | Main Arena #TCT2026 @CRFheart
64
See how the AR conversation is moving forward. Join our JenaValve-sponsored symposium at #TCT2026, Aortic Regurgitation in 2026. 🗓 Sunday, November 1 🕐 6:00–7:15 PM PST 📍 Marriott Marquis San Diego Marina | South Tower | Level 3 | Marina Ballroom D-E @crfheart The ARTIST Trial is investigational use. Limited by Federal (or United States) law to investigational use.
60
What changes for AR patients when a dedicated transcatheter option exists? A physician on how care has evolved now that there's an FDA-approved therapy for high-risk ssAR. CAUTION: US law limits these devices to sale by/on order of a physician. ISI: jenavalve.com/#isi
49
During Medical Ultrasound Awareness Month, we’re recognizing sonographers and the important role echocardiography plays in assessing aortic regurgitation and informing the patient care pathway. #MUAM #AorticRegurgitation #Echocardiography
51
As #TCT2026 approaches, we’re looking forward to connecting with the structural heart community and continuing the conversation around innovation in aortic regurgitation. 📅 October 31–November 3, 2026 📍 San Diego Convention Center | San Diego, CA @TCTConference @crfheart
1
74
We're excited to join the global cardiothoracic community in Barcelona — a city of organic, unrepeated forms. A fitting backdrop, as we believe the same about heart disease: the distinctions between conditions drive real treatment innovation. 📅 Oct 7-10 | 📍 Barcelona @EACTS #EACTS2026
78
Aortic Regurgitation can hide in plain sight. Feeling winded, tiring early, or a heart working harder can be early signs of AR. Recognizing it sooner opens more options. Know the signs: discover-AR.com CAUTION: Federal (United States) law restricts these devices to sale by or on the order of a physician. IMPORTANT SAFETY INFORMATION: See the link for full indications, contraindications, and cautions: jenavalve.com/#isi #AorticRegurgitation #HeartHealth
55
ARTIST is the first RCT comparing the Trilogy® System to surgery in low-to-intermediate risk AR. Learn more: ARTISTTrial.com CAUTION: The ARTIST Trial is investigational use. Limited by Federal (or United States) law to investigational use.
1
77
Designed for AR from the start. Trilogy®'s locator technology engages native leaflets for secure anchoring—even without calcification—and supports commissural alignment. JenaValve.com Rx only. Full IFU: jenavalve.com/ifi #Trilogy #TAVR #AorticRegurgitation
109
The JenaValve team is at DGK Heart Days in Hamburg, Sept 24-26. Come talk transcatheter treatment for AR and the science advancing care across Europe. #DGK #Kardiologie #StructuralHeart
1
139
Save the date: STS webinar "Shaping the Future of Aortic Regurgitation: A Surgical Perspective," sponsored by JenaValve. Thu Sept 24, 7 to 8 PM ET, virtual. Moderator: Vinod Thourani, MD. sts.org/webinar/sts-webinar-… #CardiacSurgery #AorticRegurgitation
84
📍 70 US sites. 30 OUS sites. One shared mission. The ARTIST trial continues to expand, bringing together heart teams around the world to advance the evidence for how we manage aortic regurgitation. Learn more: ARTISTTrial.com CAUTION The ARTIST Trial is investigational use. Limited by Federal (or United States) law to investigational use.
98
Aortic regurgitation presents a unique challenge: unlike aortic stenosis, the valve often lacks the calcification that conventional TAVR devices rely on to anchor. 🫀 This short animation shows how the Trilogy System's locator design is purpose-built to engage the native leaflets and secure the valve in regurgitant anatomy. ▶️ See how the Trilogy System is engineered for AR anatomy: jenavalve.com/trilogy-system… CAUTION: Federal (United States) law restricts these devices to sale by or on the order of a physician. IMPORTANT SAFETY INFORMATION: See the link for full indications, contraindications, and cautions: jenavalve.com/#isi #StructuralHeart #TAVR #AorticRegurgitation #MedicalAnimation #Trilogy Show less
1
125
Less than a month to go: the STS webinar "Shaping the Future of Aortic Regurgitation: A Surgical Perspective," sponsored by JenaValve. Thurs, Sept 24, 7:00 PM ET, virtual. Register here sts.org/webinar/sts-webinar-…. #CardiacSurgery #AorticRegurgitation
1
140
Save the date: "Shaping the Future of Aortic Regurgitation: A Surgical Perspective" - an STS webinar sponsored by JenaValve. Sept 24, 7:00 PM ET, virtual. Registration details coming soon. #CardiacSurgery #AorticRegurgitation
1
314